CSL, a leading biotechnology company, is seeking applications from university researchers for its Research Acceleration Initiative which aims to fast-track discovery of innovative biotherapies. Successful applicants can receive research funding of up to $400,000 over 2 years. CSL’s therapeutic areas of interest this year include, Immunology, Hematology, Respiratory, Cardiovascular and Metabolic, Transplant and Vaccines. The call for abstracts closes February 23rd 2023 and at this stage of the RAI only a brief 300 word, non-confidential abstract is needed. Learn more. If you are interested, reach out to your licensing officer at UF Innovate or email us at ufinnovatepathways@research.ufl.edu.